You are viewing the site in preview mode

Skip to main content

Table 3 Demographic and clinical characteristics of measles patients

From: Attention to COVID 19 pandemic resulted in increased measles cases and deaths in Zambia

Patient characteristics

Measles patients (N = 1259)

Died

(N = 54, 71.1%)

Alive

(N = 1209, 95.7%)

p value

N (% of total)

N (%)

N (%)

Age group

 0–4 years

736 (60.1)

35 (72.9)

701 (59.6)

 

 5–9 years

314 (25.6)

6 (12.5)

308 (26.2)

 

 10–15 years

108 (8.8)

2 (4.2)

106 (9.0)

 

 Over 15 years

66 (5.4)

5 (10.4)

61 (5.2)

0.032C

Sex

 Female

594 (47.1)

33 (61.1)

561 (46.5)

 

 Male

667 (52.9)

21 (38.9)

646 (53.5)

0.035C

Measles IGM

 Positive

205 (21.0)

13 (24.1)

192 (20.8)

 

 Negative

770 (79.0)

41 (75.9)

729 (79.2)

0.572C

Vaccinated

 Yes

207 (16.9)

3 (5.6)

965 (82.6)

 

 No

1016 (83.1)

51 (94.4)

204 (17.4)

0.023C

Fever

 Yes

1122 (89.0)

1071 (88.7)

51 (94.4)

 

 No

139 (11.0)

136 (11.3)

3 (5.6)

0.190C

Cough/Coryza

 Yes

1187 (94.4)

1136 (94.4)

51 (94.4)

 

 No

70 (5.6)

67 (5.6.5)

3 (5.6)

1.000E

Red eyes

 Yes

1123 (92.3)

49 (94.4)

1074 (92.3)

 

 No

94 (7.7)

4 (7.6)

90 (7.7)

1.000E

Runny nose

 Yes

1072 (89.4)

50 (92.6)

1022 (89.3)

 

 No

127 (10.6)

4 (7.4%)

123 (10.7)

0.649C

Rash

 Yes

857 (22.0)

42 (89.4)

815 (77.6)

 

 No

241 (857)

5 (10.6)

236 (22.4)

0.056C

  1. P: Z test of two proportions; C: Chi squared test; E: Fisher’s exact test; W: Wilcoxon rank sum test; N: number of participants; IgM: Immunoglobulin M; %: Percentage